| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.55B | -0.7% |
| Cost of Revenue | $692.1M | -3.7% |
| R&D Expense | $403.0M | -0.8% |
| SG&A Expense | $288.7M | -4.9% |
| Operating Income | $391.6M | -21.9% |
| Interest Expense | $155.2M | +1.4% |
| Pre-tax Income | $280.5M | -28.5% |
| Income Tax | $118.3M | -24.7% |
| Net Income | $162.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $565.8M | -45.1% |
| Accounts Receivable | $187.6M | +9.4% |
| Current Assets | $872.8M | -35.4% |
| Total Assets | $3.64B | +14.6% |
| Current Liabilities | $558.9M | +3.6% |
| Long-term Debt | $2.40B | -0.7% |
| Total Liabilities | $3.77B | +11.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $490.1M | -4.9% |
| Capital Expenditures | $40.9M | +25.5% |
| Investing Cash Flow | -$782.1M | -225.6% |
| Financing Cash Flow | -$167.1M | -818.1% |
| Free Cash Flow | $449.2M | -7.0% |
| -31.0% |
| EPS (Basic) | $0.44 | -31.3% |
| EPS (Diluted) | $0.44 | -31.3% |
| Stockholders' Equity |
| -$131.1M |
| +40.8% |